Analysis in detection results of apolipoprotein B and uric acid levels in patients with non-alcoholic fatty liver disease
- VernacularTitle:非酒精性脂肪肝患者载脂蛋白B及尿酸水平检测结果分析
- Author:
Shunlin HU
1
;
Min LI
;
Jiangfeng YE
;
Jing ZHANG
Author Information
- Keywords: serum uric acid; non-alcoholic fatty liver disease; correlation; apolipoprotein B; alanine aminotransferase; waist-hip ratio
- From: Journal of Clinical Medicine in Practice 2019;23(8):25-27
- CountryChina
- Language:Chinese
- Abstract: Objective To analyze the detection results of apolipoprotein B (ApoB) and serum uric acid (SUA) in patients with non-alcoholic fatty liver disease (NAFLD). Methods A total of150 NAFLD patients admitted to our hospital were selected as study group, and 150 healthy people with physical examination in the same period were as the control group. Low density lipoprotein cholesterol (LDL-C), triglyceride (TG), alanine aminotransferase (ALT), waist-hip ratio (WHR), body mass index (BMI), total cholesterol (TC), ApoB, creatinine (Cr), SUA levels were measured in the two groups. The correlation between SUA, ApoB and NAFLD was analyzed by multiple Logistic regression analysis. At the same time, smoking, coronary heart disease, diabetes and hypertension were compared between the two groups. Results The levels of LDL-C, TG, ALT, WHR, TC, BMI, SUA and ApoB in the study group were higher than those in the control group (P < 0. 05). The levels of Cr in the study group were significantly lower than those in the control group (P < 0. 05). The results of multiple Logistic regression analysis showed that the levels of SUA and ApoB were independently and positively correlated with NAFLD and were independent risk factors for NAFLD. The incidences of smoking, coronary heart disease, diabetes mellitus and hypertension were significantly higher than that of the control group (P < 0. 05). Conclusion The levels of SUA and ApoB are positively correlated with NAFLD. The higher the levels of SUA and ApoB are, the higher the incidence of cardiovascular disease is. Therefore, blood lipid intervention should be carried out in time to control the development of NAFLD.